-
Estimated Coverage With Measles Vaccine Down in 2020
Drugs
November 15, 2021
The estimated measles-containing vaccine first dose (MCV1) coverage increased globally to a peak in 2019, then decreased in 2020, according to research published in the Nov. 12 issue...
-
Bharat Biotech MD says Ideal time for COVID booster shot is six months after second dose
ExpressPharma
November 12, 2021
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said yesterday...
-
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot
Drugs
November 11, 2021
About 900,000 U.S. children aged 5 to 11 years received their initial dose of the Pfizer COVID-19 vaccine during the first week of eligibility for that age group, the Biden administration said Wednesday.
-
New protein-based COVID vaccine doesn’t need cold storage: Study
ExpressPharma
November 09, 2021
Scientists have developed a new protein-based vaccine candidate for COVID-19 that they say is much easier to produce and does not need refrigeration.
-
Ocugen seeks FDA EUA for Covid-19 vaccine use in children
Pharmaceutical-Technology
November 08, 2021
Ocugen has sought Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its Covid-19 vaccine candidate, BBV152, for use in children in the age group of two to 18 years.
-
Pfizer raises COVID vaccine sales forecast to $36 billion for 2021
ExpressPharma
November 08, 2021
Pfizer recently raised the full-year sales forecast for its COVID-19 vaccine by 7.5 per cent to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in children.
-
US authorises more batches of J&J COVID-19 vaccine made at Emergent
ExpressPharma
November 08, 2021
The US Food and Drug Administration (FDA) said it had authorised the use of two more batches of Johnson & Johnson’s one-dose COVID-19 vaccine manufactured at the problem-plagued Baltimore...
-
AHA News: What Parents Should Know About the COVID-19 Vaccine For 5- to 11-Year-Olds
Drugs
November 08, 2021
A COVID-19 vaccine has finally arrived for children ages 5 to 11 – and with it, some important questions from parents.
-
FDA provides EUA for Pfizer-BioNTech’s Covid-19 vaccine in children
Pharmaceutical-Business-Review
November 05, 2021
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Pfizer-BioNTech’s Covid-19 vaccine for children aged 5 to 11 years.
-
Cleveland Clinic launches first-of-its kind preventive breast cancer vaccine study
WorldPharmaNews
November 03, 2021
Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.